| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1084129792 |
| P356 | DOI | 10.1038/NRNEPH.2017.30 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1038/nrneph.2017.30 |
| P698 | PubMed publication ID | 28262773 |
| P50 | author | Jerzy Adamski | Q38549016 |
| Berthold Hocher | Q56879021 | ||
| P2860 | cites work | The human urine metabolome | Q21132532 |
| The human serum metabolome | Q21135549 | ||
| Prevalence of chronic kidney disease in population-based studies: systematic review | Q21257215 | ||
| Effect of slow growth on metabolism of Escherichia coli, as revealed by global metabolite pool ("metabolome") analysis | Q24521552 | ||
| Translational biomarker discovery in clinical metabolomics: an introductory tutorial | Q24598642 | ||
| A new equation to estimate glomerular filtration rate | Q24651973 | ||
| Update of the LIPID MAPS comprehensive classification system for lipids | Q24652954 | ||
| HMDB: a knowledgebase for the human metabolome | Q24655295 | ||
| Innovation in metabolomics to improve personalized healthcare | Q26830021 | ||
| Eicosanoid storm in infection and inflammation | Q26851985 | ||
| Developments in FTICR-MS and Its Potential for Body Fluid Signatures | Q26863208 | ||
| Defining the metabolome: size, flux, and regulation | Q26865192 | ||
| Biomarkers in chronic kidney disease, from kidney function to kidney damage | Q28087304 | ||
| Impact of thyroid dysfunction on serum cystatin C | Q28188663 | ||
| Human metabolic individuality in biomedical and pharmaceutical research | Q28247002 | ||
| Targets, trends, excesses, and deficiencies: refocusing clinical investigation to improve patient outcomes | Q38091580 | ||
| Role of phosphatidylinositol 3,4,5-trisphosphate in cell signaling | Q38115245 | ||
| The role of metabolomics in neonatal and pediatric laboratory medicine | Q38137608 | ||
| Aliphatic polyamines in physiology and diseases | Q38154397 | ||
| Metabolomics insights into pathophysiological mechanisms of nephrology | Q38161822 | ||
| The function of spermine | Q38176314 | ||
| L-Arginine and its metabolites in kidney and cardiovascular disease. | Q38243758 | ||
| Niacin and progression of CKD. | Q38364576 | ||
| Association of advanced age with concentrations of uraemic toxins in CKD. | Q38415397 | ||
| Mass spectrometric based approaches in urine metabolomics and biomarker discovery | Q38424072 | ||
| Cystatin C as a biomarker for estimating glomerular filtration rate. | Q38525363 | ||
| Metabolic biomarkers for chronic kidney disease. | Q38559410 | ||
| Ceramides - Lipotoxic Inducers of Metabolic Disorders | Q38594138 | ||
| Modulation of Local and Systemic Heterocellular Communication by Mechanical Forces: A Role of Endothelial Nitric Oxide Synthase. | Q38786076 | ||
| p-Cresol mediates autophagic cell death in renal proximal tubular cells | Q38911088 | ||
| Cross-Talk Between NO Synthase Isoforms in Neuro-Inflammation: Possible Implications in HIV-Associated Neurocognitive Disorders. | Q38925488 | ||
| Hormonal Regulation of Nitric Oxide (NO) in Cardio-metabolic Diseases. | Q39000523 | ||
| Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement | Q28256758 | ||
| Dimethylarginines in chronic renal failure | Q28365942 | ||
| Mining the unknown: a systems approach to metabolite identification combining genetic and metabolic information | Q28484480 | ||
| Metabolite profiles and the risk of developing diabetes | Q29615359 | ||
| 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data | Q29784220 | ||
| Reduced Renal Methylarginine Metabolism Protects against Progressive Kidney Damage | Q30300218 | ||
| Statistical methods for the analysis of high-throughput metabolomics data | Q30790493 | ||
| Plasma metabolic profiling analysis of nephrotoxicity induced by acyclovir using metabonomics coupled with multivariate data analysis | Q30826914 | ||
| Imputation of data values that are less than a detection limit | Q30941593 | ||
| Missing value imputation strategies for metabolomics data | Q30993852 | ||
| Targeted metabolomics identifies reliable and stable metabolites in human serum and plasma samples | Q31152141 | ||
| Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in renal failure patients | Q31904987 | ||
| Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems | Q33485414 | ||
| Assessment of metabolomic and proteomic biomarkers in detection and prognosis of progression of renal function in chronic kidney disease | Q33591146 | ||
| Carcinogenesis studies of cresols in rats and mice | Q33677149 | ||
| Biological significance of endogenous methylarginines that inhibit nitric oxide synthases | Q33847583 | ||
| Reliability of serum metabolite concentrations over a 4-month period using a targeted metabolomic approach | Q33941155 | ||
| A statistical framework for biomarker discovery in metabolomic time course data | Q33951348 | ||
| Serum metabolomic profiling and incident CKD among African Americans | Q34008968 | ||
| Time for food: the intimate interplay between nutrition, metabolism, and the circadian clock | Q34043586 | ||
| Long term conservation of human metabolic phenotypes and link to heritability | Q34091261 | ||
| Changes in metabolic profiles during acute kidney injury and recovery following ischemia/reperfusion | Q34142154 | ||
| The dynamic range of the human metabolome revealed by challenges | Q34198882 | ||
| Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline | Q34348423 | ||
| Urine and plasma metabolites predict the development of diabetic nephropathy in individuals with Type 2 diabetes mellitus. | Q34411671 | ||
| Systematic variations associated with renal disease uncovered by parallel metabolomics of urine and serum | Q34437046 | ||
| The use of metabolomics in population-based research | Q34471929 | ||
| Mechanism of increases in L-kynurenine and quinolinic acid in renal insufficiency | Q34510499 | ||
| Metabolic profiling of glucuronides in human urine by LC-MS/MS and partial least-squares discriminant analysis for classification and prediction of gender | Q34542935 | ||
| Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms | Q34603340 | ||
| Effects of smoking and smoking cessation on human serum metabolite profile: results from the KORA cohort study | Q34622940 | ||
| LIPID MAPS online tools for lipid research | Q34640464 | ||
| Recent advances in 17beta-hydroxysteroid dehydrogenases | Q34658537 | ||
| Optimized metabolomic approach to identify uremic solutes in plasma of stage 3-4 chronic kidney disease patients | Q34926535 | ||
| A combined epidemiologic and metabolomic approach improves CKD prediction | Q37078386 | ||
| Metabolomic markers reveal novel pathways of ageing and early development in human populations | Q37192309 | ||
| Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease | Q37260216 | ||
| Distinct metabolic profile of primary focal segmental glomerulosclerosis revealed by NMR-based metabolomics | Q37297472 | ||
| Metabolomics insights into activated redox signaling and lipid metabolism dysfunction in chronic kidney disease progression. | Q37343636 | ||
| The aging eye and the role of L-carnitine and its derivatives | Q37357256 | ||
| Plasma and urinary amino acid metabolomic profiling in patients with different levels of kidney function | Q37426982 | ||
| Metabolite profiling reveals new insights into the regulation of serum urate in humans | Q37471867 | ||
| Analytical and statistical approaches to metabolomics research | Q37537294 | ||
| Biomarkers in chronic kidney disease: a review | Q37893446 | ||
| Using high-resolution quadrupole TOF technology in DMPK analyses | Q37992702 | ||
| Application of NMR metabolomics to search for human disease biomarkers | Q38000324 | ||
| Novel methodologies in metabolic profiling with a focus on molecular diagnostic applications | Q38019000 | ||
| Role of asymmetrical dimethylarginine in the progression of renal disease | Q38046935 | ||
| The impact of CKD identification in large countries: the burden of illness | Q38056884 | ||
| Changing glucocorticoid action: 11β-hydroxysteroid dehydrogenase type 1 in acute and chronic inflammation. | Q38084054 | ||
| Acetyl-carnitine in Heart and Liver | Q58953148 | ||
| Carnitine as a Fatty Acid Carrier in Intermediary Metabolism | Q59025578 | ||
| Assay Tools for Metabolomics | Q59157152 | ||
| A meta-analysis of biomarkers related to oxidative stress and nitric oxide pathway in migraine | Q60584824 | ||
| Development of a non-targeted metabolomics method to investigate urine in a rat model of polycystic kidney disease | Q60728021 | ||
| Oxidative stress in kidney transplantation: malondialdehyde is an early predictive marker of graft dysfunction | Q61805983 | ||
| Oxidative Stress in Kidney Transplantation | Q61805996 | ||
| Amino Acid and Protein Metabolism in Diabetes Mellitus | Q66900425 | ||
| Reduced renal reabsorption of 1,5-anhydro-D-glucitol in diabetic rats and mice | Q68700121 | ||
| Chlorocresol and chloracetamide: allergens in medications, glues, and cosmetics | Q70824032 | ||
| Reduced levels of plasma 1,5-anhydroglucitol in diabetic patients | Q70945444 | ||
| Metabolism of isomers of 3-hydroxykynureninec14 to quinolinic acid, niacin metabolites and carbon dioxide | Q72758422 | ||
| Quantitative studies on the urinary excretion of indoxyl sulfate (indican) in man following administration of L-tryptophan and acetyl-L-tryptophan | Q72792130 | ||
| Oxidative stress in chronic renal failure | Q77226354 | ||
| Biomarker discovery in biological specimens (plasma, hair, liver and kidney) of diabetic mice based upon metabolite profiling using ultra-performance liquid chromatography with electrospray ionization time-of-flight mass spectrometry | Q83032278 | ||
| The renoprotective effect of L-carnitine in hypertensive rats is mediated by modulation of oxidative stress-related gene expression | Q85638926 | ||
| 1H NMR-based metabonomic analysis of serum and urine in a nonhuman primate model of diabetic nephropathy | Q86724565 | ||
| Metabolomic composition of normal aged and cataractous human lenses | Q86935241 | ||
| Metabolic profiling reveals new serum biomarkers for differentiating diabetic nephropathy | Q87423238 | ||
| Serum metabolomics study of the acute graft rejection in human renal transplantation based on liquid chromatography-mass spectrometry | Q87465662 | ||
| Asymmetric dimethylarginine and L-arginine levels in neonatal sepsis and septic shock | Q88194292 | ||
| Changes in serum metabolites with the stage of chronic kidney disease: Comparison of diabetes and non-diabetes | Q89276365 | ||
| Cytotoxic effects of p-cresol in renal epithelial tubular cells | Q39027288 | ||
| Nitric oxide: what's new to NO? | Q39038560 | ||
| Lipidomic analysis of signaling pathways. | Q40161501 | ||
| Discovery of early-stage biomarkers for diabetic kidney disease using ms-based metabolomics (FinnDiane study). | Q40403746 | ||
| Regulation of the activity of caspases by L-carnitine and palmitoylcarnitine | Q40865200 | ||
| Lipid mediator networks in cell signaling: update and impact of cytokines. | Q41073474 | ||
| Type 2 diabetes is associated with postprandial amino acid measures | Q41485002 | ||
| Metabolomics of Chronic Kidney Disease Progression: A Case-Control Analysis in the Chronic Renal Insufficiency Cohort Study | Q42042957 | ||
| Isolated isobutyryl-CoA dehydrogenase deficiency: an unrecognized defect in human valine metabolism | Q42536810 | ||
| Biomarkers and personalized therapy in chronic kidney diseases | Q42662118 | ||
| An integrated plasma and urinary metabonomic study using UHPLC-MS: intervention effects of Epimedium koreanum on 'Kidney-Yang Deficiency syndrome' rats | Q43476805 | ||
| Identification of a urine metabolomic signature in patients with advanced-stage chronic kidney disease | Q43529312 | ||
| Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11beta-hydroxysteroid dehydrogenase type 1 null mice | Q43730363 | ||
| Serum metabolite concentrations and decreased GFR in the general population | Q44085518 | ||
| Simultaneous determination of methionine sulfoxide and methionine in blood plasma using gas chromatography-mass spectrometry | Q44307988 | ||
| Toxicity of free p-cresol: a prospective and cross-sectional analysis | Q44324650 | ||
| Identification of metabolomic biomarkers for drug-induced acute kidney injury in rats | Q44559241 | ||
| The emergent role of metabolic phenotyping in dynamic patient stratification | Q45138155 | ||
| GC/TOFMS analysis of metabolites in serum and urine reveals metabolic perturbation of TCA cycle in db/db mice involved in diabetic nephropathy. | Q45398316 | ||
| Metabolomic Signatures of Chronic Kidney Disease of Diverse Etiologies in the Rats and Humans. | Q46053853 | ||
| L-carnitine supplementation and physical exercise restore age-associated decline in some mitochondrial functions in the rat. | Q46299788 | ||
| Steroid hormone synthesis in mitochondria | Q46623699 | ||
| Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure | Q46861533 | ||
| Metabolomic analysis of plasma metabolites that may mediate effects of rye bread on satiety and weight maintenance in postmenopausal women | Q47405117 | ||
| Association of Asymmetric Dimethylarginine With Acute Pancreatitis-Induced Hyperglycemia. | Q48736034 | ||
| Intracrinology in action: importance of extragonadal sex steroid biosynthesis and inactivation in peripheral tissues in both women and men. | Q50633502 | ||
| Discovery of phosphatidylcholines and sphingomyelins as biomarkers for ovarian endometriosis. | Q50922549 | ||
| Utility of urinary tubular markers for monitoring chronic tubulointerstitial injury after ischemia-reperfusion. | Q50965320 | ||
| Metabolomics as a potential new approach for investigating human reproductive disorders. | Q51013515 | ||
| A metabolomics-based approach for predicting stages of chronic kidney disease. | Q51111445 | ||
| Identifying early urinary metabolic changes with long-term environmental exposure to cadmium by mass-spectrometry-based metabolomics. | Q51139848 | ||
| Formation of Melatonin and 5-Hydroxyindole Acetic Acid from 14C-Tryptophan by Rat Pineal Glands in Organ Culture | Q51188698 | ||
| Metabolites associate with kidney function decline and incident chronic kidney disease in the general population. | Q51216532 | ||
| Plasma arginine/ADMA ratio as a sensitive risk marker for atherosclerosis: Shimane CoHRE study. | Q51309660 | ||
| Endogenous metabolites and inflammasome activity in early childhood and links to respiratory diseases. | Q51651482 | ||
| The effects of butylated hydroxyanisole and butylated hydroxytoluene on renal function in the rat. I. Effects on fluid and electrolyte excretion. | Q51659854 | ||
| Metabonomics evaluation of urine from rats administered with phorate under long-term and low-level exposure by ultra-performance liquid chromatography-mass spectrometry. | Q52748551 | ||
| Evaluation of various biomarkers as potential mediators of the association between coffee consumption and incident type 2 diabetes in the EPIC-Potsdam Study. | Q52875110 | ||
| Dialysis modality-dependent changes in serum metabolites: accumulation of inosine and hypoxanthine in patients on haemodialysis. | Q53458311 | ||
| A high-performance liquid chromatography-tandem mass spectrometry-based targeted metabolomics kidney dysfunction marker panel in human urine. | Q53543397 | ||
| Identification of aristolochic acid in Chinese herbs. | Q55065510 | ||
| On a Test of Whether one of Two Random Variables is Stochastically Larger than the Other | Q55953061 | ||
| Orthogonal projections to latent structures (O-PLS) | Q56435041 | ||
| Use of Ranks in One-Criterion Variance Analysis | Q56481762 | ||
| Standard operating procedures for pre-analytical handling of blood and urine for metabolomic studies and biobanks | Q57975695 | ||
| Stability and Robustness of Human Metabolic Phenotypes in Response to Sequential Food Challenges | Q58045554 | ||
| The evolution of partial least squares models and related chemometric approaches in metabonomics and metabolic phenotyping | Q58045688 | ||
| Impact of cholesterol lowering treatment on plasma kynurenine and tryptophan concentrations in chronic kidney disease: Relationship with oxidative stress improvement | Q58294541 | ||
| The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia | Q34952514 | ||
| Combining serum cystatin C with total bilirubin improves short-term mortality prediction in patients with HBV-related acute-on-chronic liver failure | Q35023406 | ||
| A mitochondrial carnitine acylcarnitine translocase system | Q35072156 | ||
| Metabolite profiling and cardiovascular event risk: a prospective study of 3 population-based cohorts | Q35152158 | ||
| Pre-analytical sample quality: metabolite ratios as an intrinsic marker for prolonged room temperature exposure of serum samples | Q35590383 | ||
| Urinary metabolomics and biomarkers of aristolochic acid nephrotoxicity by UPLC-QTOF/HDMS. | Q35600812 | ||
| Grade-Dependent Metabolic Reprogramming in Kidney Cancer Revealed by Combined Proteomics and Metabolomics Analysis | Q35752074 | ||
| Effects of pre-analytical processes on blood samples used in metabolomics studies | Q35753268 | ||
| A systems view of type 2 diabetes-associated metabolic perturbations in saliva, blood and urine at different timescales of glycaemic control | Q35842441 | ||
| NMR-Based Metabolic Snapshot from Minibronchoalveolar Lavage Fluid: An Approach To Unfold Human Respiratory Metabolomics. | Q35846973 | ||
| Triple quadrupole linear ion trap mass spectrometer for the analysis of small molecules and macromolecules | Q35871436 | ||
| Metabolomics analysis reveals the association between lipid abnormalities and oxidative stress, inflammation, fibrosis, and Nrf2 dysfunction in aristolochic acid-induced nephropathy | Q35926121 | ||
| Metabolomics: an emerging post-genomic tool for nutrition | Q35937192 | ||
| Plasma metabolomic profiles enhance precision medicine for volunteers of normal health | Q36055457 | ||
| 11beta-hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action | Q36217956 | ||
| Stress hormone and male reproductive function | Q36218267 | ||
| Genome-wide association studies with metabolomics | Q36245152 | ||
| Urinary Biomarkers and Risk of ESRD in the Atherosclerosis Risk in Communities Study | Q36250287 | ||
| Novel biomarkers for pre-diabetes identified by metabolomics | Q36321634 | ||
| Mass spectrometers for the analysis of biomolecules | Q36364161 | ||
| The Cinderella story of metabolic profiling: does metabolomics get to go to the functional genomics ball? | Q36428339 | ||
| Human serum metabolic profiles are age dependent | Q36498753 | ||
| Metabolomics Reveals a Key Role for Fumarate in Mediating the Effects of NADPH Oxidase 4 in Diabetic Kidney Disease | Q36514979 | ||
| Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach | Q36560652 | ||
| Plasma metabolomic profiles in different stages of CKD. | Q36652795 | ||
| A Metabolome-Wide Association Study of Kidney Function and Disease in the General Population | Q36746035 | ||
| Urinary metabolomic markers of aminoglycoside nephrotoxicity in newborn rats | Q36807292 | ||
| 11beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress | Q36833926 | ||
| Identification of biomarkers for development of end-stage kidney disease in chronic kidney disease by metabolomic profiling | Q36910790 | ||
| Associations of urinary levels of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) with kidney function decline in the Multi-Ethnic Study of Atherosclerosis (MESA). | Q36950546 | ||
| Nitric oxide deficiency in chronic kidney disease | Q36967585 | ||
| Alcohol-induced metabolomic differences in humans | Q37065278 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | metabolomics | Q12149006 |
| P304 | page(s) | 269-284 | |
| P577 | publication date | 2017-03-06 | |
| P1433 | published in | Nature Reviews Nephrology | Q2079275 |
| P1476 | title | Metabolomics for clinical use and research in chronic kidney disease | |
| P478 | volume | 13 |
| Q89641922 | A Functional Landscape of CKD Entities From Public Transcriptomic Data |
| Q93129177 | Aryl hydrocarbon receptor activation mediates kidney disease and renal cell carcinoma |
| Q51412140 | Associations of Plasma Amino Acid and Acylcarnitine Profiles with Incident Reduced Glomerular Filtration Rate. |
| Q41662786 | Chemical Analysis of Astragali Complanati Semen and Its Hypocholesterolemic Effect Using Serum Metabolomics Based on Gas Chromatography-Mass Spectrometry |
| Q41459702 | Disease-syndrome combination modeling: metabolomic strategy for the pathogenesis of chronic kidney disease |
| Q46124690 | Effect of rosuvastatin on fasting and postprandial endothelial biomarker levels and microvascular reactivity in patients with type 2 diabetes and dyslipidemia: a preliminary report |
| Q55002257 | Effects of linagliptin on endothelial function and postprandial lipids in coronary artery disease patients with early diabetes: a randomized, placebo-controlled, double-blind trial. |
| Q45017953 | Elucidation of complexity and prediction of interactions in microbial communities |
| Q101574185 | Exploring blood alterations in chronic kidney disease and haemodialysis using metabolomics |
| Q90421257 | Fecal microbiota analysis of polycystic kidney disease patients according to renal function: A pilot study |
| Q56969403 | Folate treatment of pregnant rat dams abolishes metabolic effects in female offspring induced by a paternal pre-conception unhealthy diet |
| Q47571217 | Hope for CKD-MBD Patients: New Diagnostic Approaches for Better Treatment of CKD-MBD. |
| Q47554803 | METLIN: A Technology Platform for Identifying Knowns and Unknowns. |
| Q57265612 | MetaboRank: network-based recommendation system to interpret and enrich metabolomics results |
| Q49668451 | Metabolite profiles of healthy aging index are associated with cardiovascular disease in African Americans: the Health, Aging, and Body Composition Study. |
| Q47710032 | Metabolomic Alterations Associated with Cause of CKD. |
| Q91643294 | Metabolomic and biochemical characterization of a new model of the transition of acute kidney injury to chronic kidney disease induced by folic acid |
| Q90264191 | Metabolomics Analysis Reveals the Protection Mechanism of Huangqi-Danshen Decoction on Adenine-Induced Chronic Kidney Disease in Rats |
| Q64252507 | Metabolomics Approaches for the Diagnosis and Understanding of Kidney Diseases |
| Q64965132 | Metabolomics Research in Chronic Kidney Disease. |
| Q89130223 | Metabolomics and Kidney Precision Medicine |
| Q47205404 | Metabolomics technology and bioinformatics for precision medicine. |
| Q91011956 | Molecular Imaging of Endometriosis Tissues using Desorption Electrospray Ionization Mass Spectrometry |
| Q47604834 | Monitoring wastewater for assessing community health: Sewage Chemical-Information Mining (SCIM). |
| Q94073532 | Multi-functional derivatization of amine, hydroxyl, and carboxylate groups for metabolomic investigations of human tissue by electrospray ionization mass spectrometry |
| Q49990145 | Navigating T-Cell Immunometabolism in Transplantation. |
| Q47922360 | New perspectives on CKD-induced dyslipidemia. |
| Q91344766 | Non-invasive differentiation of non-rejection kidney injury from acute rejection in pediatric renal transplant recipients |
| Q88944201 | Non-invasive staging of chronic kidney allograft damage using urine metabolomic profiling |
| Q93165799 | Overall Similarities and a Possible Factor Affecting Plasma Metabolome Profiles Between Venous and Capillary Blood Samples From 20 Healthy Human Males |
| Q64052137 | PPARα contributes to protection against metabolic and inflammatory derangements associated with acute kidney injury in experimental sepsis |
| Q60917763 | Plasma acylcarnitines could predict prognosis and evaluate treatment of IgA nephropathy |
| Q64103930 | Plasma metabolites and lipids associate with kidney function and kidney volume in hypertensive ADPKD patients early in the disease course |
| Q93178699 | Population-Level Analysis to Determine Parameters That Drive Variation in the Plasma Metabolite Profiles |
| Q88732409 | Serum 6-Bromotryptophan Levels Identified as a Risk Factor for CKD Progression |
| Q49489722 | Serum Metabolomic Profiling of All-Cause Mortality: A Prospective Analysis in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study Cohort. |
| Q33893655 | Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, all-cause mortality and deterioration in kidney function in persons with type 2 diabetes and microalbuminuria |
| Q52341285 | The Promise of Systems Biology for Diabetic Kidney Disease. |
| Q52618381 | The Warburg Effect in Diabetic Kidney Disease. |
| Q64054439 | The combination of a neprilysin inhibitor (sacubitril) and angiotensin-II receptor blocker (valsartan) attenuates glomerular and tubular injury in the Zucker Obese rat |
| Q57053846 | The metabolomic quest for a biomarker in chronic kidney disease |
| Q98164380 | The relationship between blood metabolites of the tryptophan pathway and kidney function: a bidirectional Mendelian randomization analysis |
| Q52688968 | The role of renal dipeptidyl peptidase-4 in kidney disease: renal effects of dipeptidyl peptidase-4 inhibitors with a focus on linagliptin. |
| Q46271397 | Untargeted mass spectrometry discloses plasma solute levels poorly controlled by hemodialysis |
| Q64072230 | Untargeted metabolomics reveals N, N, N-trimethyl-L-alanyl-L-proline betaine (TMAP) as a novel biomarker of kidney function |
| Q89696036 | Urinary chemical fingerprint left behind by repeated NSAID administration: Discovery of putative biomarkers using artificial intelligence |
| Q49632078 | Urine metabolomics insight into acute kidney injury point to oxidative stress disruptions in energy generation and H2S availability. |
| Q90681098 | Variability of Two Metabolomic Platforms in CKD |
| Q90004616 | [Acute kidney injury: from creatinine to KIM‑1?] |
Search more.